Radcliffe Capital Management, L.P. - MONTEREY BIO ACQUISITION COR ownership

MONTEREY BIO ACQUISITION COR's ticker is and the CUSIP is 61240F116. A total of 26 filers reported holding MONTEREY BIO ACQUISITION COR in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of MONTEREY BIO ACQUISITION COR
ValueSharesWeighting
Q3 2023$5,000
-12.7%
200,0000.0%0.00%
Q2 2023$5,730
+0.5%
200,0000.0%0.00%
Q1 2023$5,700
-99.7%
200,0000.0%0.00%
-100.0%
Q4 2022$2,100,000
+3.9%
200,0000.0%0.07%
+34.7%
Q3 2022$2,022,000
+0.9%
200,0000.0%0.05%
+6.5%
Q2 2022$2,004,000
+0.6%
200,0000.0%0.05%
+2.2%
Q1 2022$1,993,000
+0.9%
200,0000.0%0.04%
-13.5%
Q4 2021$1,975,000200,0000.05%
Other shareholders
MONTEREY BIO ACQUISITION COR shareholders Q1 2022
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 276,634$3,087,2350.23%
BOOTHBAY FUND MANAGEMENT, LLC 388,437$4,334,9570.10%
ATW SPAC MANAGEMENT LLC 384,993$11,0490.02%
EHP Funds Inc. 938,629$26,9380.01%
MMCAP International Inc. SPC 625,000$17,9380.01%
Arena Investors LP 133,500$3,3380.00%
Spartan Fund Management Inc. 75,000$2,1520.00%
PERISCOPE CAPITAL INC. 531,200$15,2450.00%
HGC Investment Management Inc. 160,000$4,5920.00%
CVI Holdings, LLC 15,075$4330.00%
View complete list of MONTEREY BIO ACQUISITION COR shareholders